Best Healthcare Technology Stocks To Invest In 2014

SolarCity (SCTY) leases solar panels. Tesla Motors (TSLA) manufactures and sells electric cars. And as we all know, they’re both the brainchild of one man: Elon Musk.

Reuters

Which got me thinking: Does that link impact how Tesla and Solar City trade? On first glance, it sure appears that way. Today, for instance, SolarCity has dropped 4.7% after it beat fourth-quarter earnings forecasts but guided below Street expectations for the current quarter. Tesla, with little meaningful news of its own unless you count this, has fallen 1.5%.

To see if there was more than anecdotal evidence, I ran the 24-day correlation (essentially one month of trading) between SolarCity and Tesla. A correlation of 100% means two stocks move in lockstep, while a correlation of -100% means they move in complete opposition. Right now, the correlation between the two stocks is 61.1%, well above the 12-month average of 37.7%. During the past 12 months, the correlation between the two stocks has been as low as -39.8%, which means they were generally heading in opposite directions during that period–and as high as 77.9%, meaning they were pretty much marching to the beat of the same drummer.

Top 5 Life Sciences Companies To Buy Right Now: Graham Corp (GHM)

Graham Corporation (Graham), incorporated on March 7, 1983, designs, manufactures and sells critical equipment for the energy industry which includes the oil refining, petrochemical, as well as cogeneration, nuclear and alternative power markets. It design and manufacture custom-engineered ejectors, pumps, surface condensers and vacuum systems as well as supplies and components for inside the reactor vessel and outside the containment vessel of nuclear power facilities. Its equipment is also used in nuclear propulsion power systems for the defense industry and can be found in other diverse applications such as metal refining, pulp and paper processing, water heating, refrigeration, desalination, food processing, pharmaceutical, heating, ventilating and air conditioning. The Company�� two wholly owned subsidiaries include Graham Vacuum and Heat transfers Technology (Suzhou) Co., Ltd.

The Company's products are used in a range of industrial process applications, including Chemical and Petrochemical Processing, such as ethylene, methanol and nitrogen producing plants, plastics, resins and fibers plants and petrochemical intermediate plants, and Power Generation /Alternative Energy, such as propulsion systems for nuclear-powered aircraft carriers and other nuclear- powered vessels, air conditioning and water heating systems and liquefied natural gas production facilities. The Company's principal customers are in the chemical, petrochemical, petroleum refining and power generating industries, and are users of the Company's products in their manufacturing, refining and power generation processes, large engineering companies that build installations for companies in such industries, and/or the original equipment manufacturers, who combine its products with their equipment prior to its sale to end users.

The Company competes with Gardner Denver, Inc., GEA Wiegand GmbH, Edwards, Ltd, Korting Hannover AG, Croll Reynolds Company, Inc, Schutte Koerting, Gardner Denver, Inc, DongHwa En! tec Co., Ltd, Hangzhou Turbine Equipment Co., Chem Process Systems, Mazda (India), Oeltechnik GmbH, KEMCO, Holtec, Thermal Engineering International, SPX Heat Transfer, Chem Process Systems, Mazda (India)., Ambassador, Alfa Laval AB, APV, Xylem, Dubose, Consolidated, Tioga, Nova, Joseph Oats and Energy & Process.

Advisors' Opinion:

• [By Rick Munarriz]

  Friday
  The market is typically quiet on Friday, but don't tell that to Graham (NYSEMKT: GHM  ) . The maker of custom-engineered ejectors, pumps, condensers, vacuum systems, and heat exchangers reports on Friday morning. Analysts see profitability almost quadrupling to $0.31 a share, and revenue soaring 48%.

Best Healthcare Technology Stocks To Invest In 2014: C&J Energy Services Inc (CJES)

C&J Energy Services, Inc., incorporated on December 15, 2010, is a provider of hydraulic fracturing, coiled tubing, wireline and other complementary services with a focus on complex, technically demanding well completions. The Company also manufactures and repairs equipment to fulfill its internal needs and for third-party companies in the energy services industry. The Company operates in three reportable segments: Stimulation and Well Intervention Services, Wireline Services and Equipment Manufacturing.

The Company provides hydraulic fracturing coiled tubing and related well intervention services through its Stimulation and Well Intervention Services segment to oil and natural gas exploration and production companies. On June 7, 2012, the Company acquired Casedhole Holdings, Inc. and its operating subsidiaries, including Casedhole Solutions, Inc.

Stimulation and Well Intervention Services

The Company's Stimulation and Well Intervention Services segment provides hydraulic fracturing and coiled tubing and other well intervention services, with a focus on complex, technically demanding well completions. The Company's customers use the Company's hydraulic fracturing services to enhance the production of oil and natural gas from formations with low permeability, which restricts the natural flow of hydrocarbons. Hydraulic fracturing involves pumping a fluid down a well casing or tubing at sufficient pressure to cause the underground producing formation to fracture, allowing the oil or natural gas to flow more freely. The Company's engineering staff also provides technical evaluation, job design and fluid recommendations for the Company's customers as an integral element of its fracturing service. The Company's engineering staff also provides technical evaluation, job design and fluid recommendations for the Company's customers as an integral element of its fracturing service.

Wireline Services

The Company's Wireline Services segment p! rovides cased-hole wireline and other complementary services. Its services includes logging, perforating, pipe recovery, pressure testing and pumpdown services, which are critical throughout a well's life cycle.

Equipment Manufacturing

The Company's Equipment Manufacturing segment constructs oilfield equipment, including hydraulic fracturing pumps, coiled tubing units, pressure pumping units and other equipment for the Company's Stimulation and Well Intervention Services and Wireline Services segments as well as for third-party customers in the energy services industry. This segment also provides equipment repair services and oilfield parts and supplies to the energy services industry and to meet the Company's own internal needs.

The Company competes with Halliburton, Schlumberger, Baker Hughes, Weatherford International, RPC, Inc., Pumpco, an affiliate of Superior Energy Services, Frac Tech, Stewart & Stevenson, Enerflow Industries Inc., United Engines Manufacturing, Dragon Products and National Oilwell Varco, Inc.

Advisors' Opinion:

• [By Traders Reserve]

  C&J Energy Services (CJES) grew more than 25% in 2012, after tripling in 2011, but has stalled in 2013 and will come in with near-zero growth. Part of the reason is the softening of oil prices and the shuttering marginal fields ��C&J Energy Services provides fracking-related oil field services on a spot basis with prices defined under long-term contracts.

• [By Matt DiLallo]

  C&J Energy Services (NYSE: CJES  )
  One of the more interesting purchases this quarter is the $7.4 million Soros poured into C&J Energy Services. The oilfield service company specializes in complex well completions, making it an important company for extracting ever-harder-to-reach oil and gas. With operations spanning the most active shale plays, an investment in C&J is one that benefits as oil and gas companies drill more wells using even more complex hydraulic fracturing techniques.

• [By Aaron Levitt]

  For investors, the choice is clear — you need to focus globally when it comes to oil stocks. North American-focused oil stocks like C&J Energy (CJES) and Basic Energy Services (BAS) might not be up to snuff in such a highly challenging pricing environment.

• [By Lee Jackson]

  C&J Energy Services Inc. (NYSE: CJES) undertook an aggressive expansion plan for 2013. That strategy culminated in several deals during the fourth quarter and further plans for 2014. The domestic hydraulic fracturing specialist has spent the past couple of years expanding the business line and, surprisingly, building new equipment. Now with natural gas inventories plunging to five-year lows, C&J Energy is positioned to take advantage of a market where utilization is already firming. Jefferies price target holds steady at $28, and the consensus estimate is $25. Shares closed Friday at $24.50.

Best Healthcare Technology Stocks To Invest In 2014: Turkiye Halk Bankasi AS (HALKB)

Turkiye Halk Bankasi A.S. (Halkbank) is a Turkey-based bank that provides banking products and services to a range of customers, including tradesmen, small- to medium-sized enterprises (SME) and large corporations. The Company�� segments are: consumer and retail banking, which offers consumer loans, credit and debit cards, deposit and overdraft accounts and payroll services; corporate and commercial banking, each offering assistance loans targeting specific sectors, budget loans, domestic and international non-cash credit line facilities, such as letters of credit and guarantees, cash management, investment banking, brokerage, factoring, leasing and insurance services for clients with varying annual turnovers, and tradesmen/SME banking. It also offers telephone, Internet, mobile and television banking services. Advisors' Opinion:

• [By Harry Suhartono]

  The Borsa Istanbul National 100 Index jumped 3.7 percent, the most among major emerging-market gauges, as Akbank TAS (AKBNK) and Turkiye Halk Bankasi AS (HALKB) rallied. Benchmark measures in Poland and the Czech Republic added at least 0.5 percent, while Hungarian shares retreated for a fourth day.

Best Healthcare Technology Stocks To Invest In 2014: Antofagasta PLC (ANTO)

Antofagasta plc (Antofagasta) is a Chile-based copper mining company with interests in transport and water distribution. The Company operates in three segments: Mining, Transport and Water. Antofagasta is a holding company that operates through its subsidiaries, associates and joint ventures. The principal activities of the Company are copper mining (including exploration and development), the transportation of freight by rail and road and the distribution of water. Its mining operations produce copper with by-products of gold, molybdenum and silver. Its activities are mainly concentrated in Chile. The Company�� segments include Los Pelambres, Esperanza, El Tesoro, Michilla, Antucoya, Exploration and evaluation, Railway and other transport services, Water concession, and Corporate and other items. Advisors' Opinion:

• [By Sarah Jones]

  Among commodity producers, Antofagasta (ANTO) Plc rose 1.4 percent to 904 pence as base metals advanced in London. Glencore Xstrata added 3.2 percent to 315.9 pence and Rio Tinto Group increased 1 percent to 2,786 pence.

• [By Namitha Jagadeesh]

  British American Tobacco Plc and Imperial Tobacco Group Plc (IMT) each lost at least 1.5 percent as American peer Philip Morris International Inc. forecast 2014 profit growth below its long-term target. Antofagasta Plc (ANTO) and Vedanta Resources Plc (VED) followed miners lower, sliding at least 2 percent. Johnson Matthey Plc (JMAT) gained 3.9 percent after posting better-than-forecast profit and raising its dividend.

• [By Sarah Jones]

  Rio Tinto, the world�� second-largest mining company, fell 2.7 percent to 2,959.5 pence. Anglo American dropped 2.6 percent to 1,606 pence and Antofagasta Plc (ANTO), which mines for copper in Chile, retreated 3.9 percent to 916 pence.

• [By Jonathan Morgan]

  Anglo American and Rio Tinto retreated 2.8 percent to 1,421.5 pence and 2.4 percent to 2,740 pence, respectively. Lonmin Plc, the world�� third-largest platinum producer, slipped 3.2 percent to 287.6 pence. Antofagasta Plc (ANTO), the Chilean copper producer, declined 1.2 percent to 911 pence.

Best Healthcare Technology Stocks To Invest In 2014: Barclays PLC (II)

Barclays PLC (Barclays) is a global financial services provider engaged in retail banking, credit cards, wholesale banking, investment banking, wealth management and investment management services. The Company�� operations include its overseas offices, subsidiaries and associates. The Company operates in eight segments: UK Retail and Business Banking (UK RBB), Europe Retail and Business Banking (Europe RBB), Africa Retail and Business Banking (Africa RBB), Barclaycard, Barclays Investment Bank, Barclays Corporate Banking, Wealth and Investment Management, and Head Office and Other Operations. Advisors' Opinion:

• [By Todd Sullivan]

  HHC has increased all our ownership percentage through the repurchasing of outstanding warrants.

  From the 13D/A
  On December 31, 2013, certain of the Reporting Persons entered into swaps for the benefit of certain Pershing Square Funds. Under the terms of the swaps, (i) the relevant Pershing Square Funds will be obligated to pay to the bank counterparty any negative price performance of the 5,399,839 notional number of Common Shares subject to the swaps as of the expiration date of such swaps, plus interest rates set forth in the applicable contracts, and (ii) the bank counterparty will be obligated to pay the relevant Pershing Square Funds any positive price performance of the 5,399,839 notional number Common Shares subject to the swaps as of the expiration date of the swaps. During the term of the swaps, cash will be paid by the bank counterparty to the relevant Pershing Square Fund in an amount equal to the amount of notional distributions or dividends paid by the Issuer in respect of such notional number of Common Shares. All balances will be settled in cash. The Pershing Square Funds��counterparties for the swaps include entities related to Citibank, Nomura, Soci茅t茅 G茅n茅rale and UBS. The swaps do not give the Reporting Persons direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparty thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership of any Common Shares that may be referenced in the swap contracts or Common Shares or other securities or financial instruments that may be held from time to time by any counterparty to the contracts.

• [By Robert Abbott]

  The company lists competitive factors this way, and in this order in its 10-K: "...(i) vendor and product reputation; (ii) product quality, performance and price; (iii) the availability of software products on multiple platforms; (iv) product scalability; (v) product integration with other enterprise applications; (vi) software functionality and features; (vii) software ease of use; (viii) the quality of professional services, customer support services and training; and (ix) the ability to address specific customer business problems."

• [By Holly LaFon]

  Performance data quoted represents past performance and is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Investment return and principal value will fluctuate so that an investor's shares, when redeemed, may be worth more or less than original cost. As stated in the current prospectus, the Fund�� Investor Class Share�� annual operating expense ratio (gross) is 1.28%. The Fund�� adviser has contractually agreed to waive a portion of its fee and/or reimburse Fund expenses to limit total annual operating expenses at 1.25%, which is in effect until October 31, 2015. Other share classes may vary. The Fund charges a 2.0% redemption fee on shares redeemed within six months of purchase. For the most recent month-end performance, please call (877)328-9437 or visit the Advisor�� website at www.auxierasset.com. The recent growth rate in the stock market has helped to produce short-term returns that are not typical and may not continue in the future.Spring 2014 Market CommentaryAuxier Focus Fund�� Investor Class returned a modest 0.25% for the quarter ended March 31, while Standard and Poor�� 500 Stock Index (S&P) rose 1.81%. The Fund ended the quarter with 70% in U.S. stocks, 16% foreign stocks, 1.7 % bonds and 12.3% cash. Since inception in 1999, the Fund�� equity exposure has averaged 72%. Our stockholdings in the healthcare industry generally gained for the quarter. But many of our multinational and foreign stocks were hurt by the threat of currency repercussions from geopolitical events in Russia and Ukraine. The foreign portion of the Fund is easily the most undervalued. Longer term, we see a very favorable risk/reward potential with our UK and European holdings. Some emerging market companies we follow are the cheapest in over twenty years. In allocating capital, we much prefer the gloom of down to flat markets and the corrective process that tempers exuberance. We remember that one of th

Best Healthcare Technology Stocks To Invest In 2014: Ishares Msci Italy Index Fund (EWI)

iShares MSCI Italy Index Fund (the Fund) seeks to provide investment results that correspond generally to the price and yield performance of publicly traded securities in the aggregate in the Italian market, as measured by the MSCI Italy Index (the Index). The Index seeks to measure the performance of the Italian equity market. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization. Component companies are adjusted for available float and must meet objective criteria for inclusion in the Index. The Index is reviewed quarterly.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By Dan Caplinger]

  4. Italy
  Some developed markets have also outperformed the Dow Jones Industrials. Italy's market is up 14%, and even the euro's weakness has given U.S. investors in iShares MSCI Italy (NYSEMKT: EWI  ) a 12% gain. Europe has made progress toward emerging from recession, and Italy has recovered more than some of its economically healthier peers because of the close brush with sovereign-debt issues that cut confidence in the Mediterranean nation's stock market substantially. As long as the government can keep debt under control, Italy could keep outperforming the Dow.

• [By Tom Aspray]

  This is quite a bit better than the 9.2% gain of the iShares MSCI Italy (EWI) or the 8.9% rise in the iShares MSCI Austria (EWO). All three have done significantly better than the Spyder Trust (SPY), which is up 3.6%. The French and German country ETFs have not yet moved above their late 2013 highs.

• [By Dan Caplinger and Mike Klesta]

  In the following video, Fool markets analyst Mike Klesta talks with Fool contributor Dan Caplinger about three countries with particularly high unemployment rates. As Dan notes, even though the employment picture in Europe is ugly, one of these three countries has made some progress toward getting unemployment under control. Dan also weighs in with some investment ideas for those seeking to bet on a turnaround in Europe, with thoughts for both ETF investors and those who prefer individual stocks (NYSEMKT: EWI  ) .

Best Healthcare Technology Stocks To Invest In 2014: Sigma Labs Inc (SGLB)

Sigma Labs, Inc., incorporated on December 23, 1985, has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies, as well as Reasearch and Development solutions for first-tier integrators and other commercial firms worldwide. Sumner Associates provide consultants to Federal government and commercial clients seeking productive solutions for development technologies. As of December 31, 2012, the Company is engaged in a range of activities, in which it seek to commercialize technologies and products in the industry sectors, which include in process quality assurance for manufacturing; aerospace and defense manufacturing; additive manufacturing; active protection systems for defending light armored vehicles; advanced materials for munitions; advanced materials for sporting goods; advanced manufacturing technologies, and dental implant and biomedical prosthetics technologies.

Sumner & Lawrence Limited (Sumner), based in Santa Fe, New Mexico, provides consulting services to the public sector, especially with regard to emerging technologies and alternative applications of established technologies. Sumner holds ongoing contracts with government agencies and the appropriate levels of security clearance for those contracts. Sumner's clients include the State Department, the Department of Defense, the Department of Energy, various military services and affiliated agencies, the National Laboratories, and contractors to these organizations.

Advisors' Opinion:

• [By James E. Brumley]

  For veteran traders who've kept tabs on Sigma Labs Inc. (OTCMKTS:SGLB) over the past three months or so, it may be surprising to hear someone suggest it as a buy. Like so many other stocks of its ilk have done since the beginning of the organized market, SGLB went from (proverbially) zero to hero between late May and mid-July with a move from $0.025 to a peak of $0.118 only to fall back to the $0.04 level a couple of weeks later. It's the relatively common "one hit wonder", and if Sigma Labs followed the usual pattern of other small stocks that burned brilliantly for a few days, we wouldn't see anything particularly bullish from SGLB for a few months, if not years.